Heart failure is a condition in which the heart is unable to pump enough blood to meet the body's needs. Chronic heart failure develops gradually over time and is often diagnosed late because its symptoms can be non-specific. Early diagnosis and treatment of heart failure can help improve the patient's quality of life. 

  A study conducted at Mersin University in Turkey found that 86% of patients flagged by qXR as having a risk of incidental heart failure were confirmed to have the condition upon further clinical evaluation. This means that qXR can aid in early detection, timely treatment, and fewer complications, potentially reducing length of stay and mortality rates associated with heart failure.